DOCSLIB.ORG

Cambridge University Press 978-1-108-81783-7 — Reproductive Medicine for the MRCOG Edited by Siladitya Bhattacharya , Mark Hamilton Index More Information

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cambridge University Press 978-1-108-81783-7 — Reproductive Medicine for the MRCOG Edited by Siladitya Bhattacharya , Mark Hamilton Index More Information Cambridge University Press 978-1-108-81783-7 — Reproductive Medicine for the MRCOG Edited by Siladitya Bhattacharya , Mark Hamilton Index More Information Index access, to fertility treatment, 137–40 arcuate uterus, 41 body mass index (BMI), 9, 10 adenomyosis, 33, 40 aromatase inhibitors, 16, 29 bromocriptine, 19 adhesions ART. See assisted reproduction buffers, culture media, 95–6 intrauterine, 33–4, 35, 40, 41 technology tubal, 31 AS. See Asherman’s syndrome cabergoline, 19 adjuvants/add-ons in assisted ASFR. See Age-Specific Fertility Rate calcium ionophores, 89, 103 reproduction, 91 Asherman’s syndrome (AS), 33–4, 35, cancer treatment, 113. See also fertility artificial egg activation with calcium 40, 41 preservation ionophore, 89, 103 ASRM. See American Society for gonadotoxicity risks of, 113, 114 assisted hatching, 86 Reproductive Medicine mechanisms of fertility damage by, background on, 82–3 assessment. See also infertility 114–15 commonly used, 83–4 assessment ovarian reserve damage by, 114–15 costs of, 83 of donors, surrogates and intended pregnancy outcomes after, 120 embryo glue, 88 parents, 129–30 testicular damage caused by, 46, 115 endometrial receptivity array, 87 embryo, 105–6, 107 CAT. See chlamydia antibody testing endometrial scratching, 84–5, 86 of fertilisation, 101–2, 103 catheters, for embryo transfer, 73 GM-CSF-containing culture media, for fertility preservation, 116–17 CBRS. See cross border reproductive 88 assisted hatching, 86 services IMSI, 89, 101–2 assisted reproduction technology CC. See clomiphene citrate PICSI, 89–90, 101–2 (ART), 68. See also adjuvants/add- Centre for Evidence Based Medicine preimplantation genetic screening, ons in assisted reproduction; (CEBM), 150–1 87, 109–10 laboratory procedures in assisted CF. See cystic fibrosis professional and regulatory body reproduction; specific techniques chemical motility enhancers, 98–9 stances on, 83 access to treatment with, 137–40 chemotherapy. See cancer treatment reproductive immunology decision to stop treatment with, children procedures, 90–1 80–1 disclosure of third-party sperm DNA tests, 90 HFEA role in, 80 conception to, 128–9 time-lapse imaging, 85–6, 106 male factor infertility treatment genetic identity of, 144–5 adoption, 138–9 options in, 52–3 interests and welfare of, 80, 129–30, Age-Specific Fertility Rate (ASFR), techniques used in, 68 137–8, 143, 145, 146 1, 3 unsuccessful, 80–1 posthumous, 120–1, 141–3 air, laboratory, 96 audits, 164 risks to IVF/ICSI conceived, 79 alcohol intake, 8–9, 10, 25–6, 46 autonomy, patient, 136, 137, 140–1, chlamydia antibody testing (CAT), 35 American Society for Reproductive 146 Chlamydia trachomatis, 8, 31, 46 Medicine (ASRM), 24 azoospermia class II cabinets, 94, 95 AMH. See anti-mullerian hormone assisted reproduction treatment cleavage stage embryo transfer, 74 andrology. See male factor infertility options for, 52–3 clinical decision making, 147 anejaculation, 46–7 causes of, 45–7 clinical governance, 163 aneuploidy, PGT for, 87, 109–10 medical treatment options for, 51–2 audits, 164 anorgasmia, 47 surgical treatment options for, 52 external review, 165 anovulatory infertility. See ovulation quality inspections, 164 disorders baby design, 146 quality sampling, 164 antibody testing bacterial vaginosis, 8 quality tours, 164–5 chlamydia, 35 bias, 151–2, 153 risk management/risk assessment, sperm, 51 bicornuate uterus, 41 164 thyroid autoantibodies, 8, 9 biomarkers, for endometriosis, 27 clinical practice guidelines, 153–4 anti-mullerian hormone (AMH), 8 biopsy clomiphene citrate (CC), 14–15, 51–2, antioestrogens, 14–15, 118 embryo, 110–11 56 antiprogestogens, 29 testicular, 51 cocaine use, 9 antral follicle count, 8 blastocyst transfer, 74 Cochrane risk of bias tool, 151–2 167 © in this web service Cambridge University Press www.cambridge.org Cambridge University Press 978-1-108-81783-7 — Reproductive Medicine for the MRCOG Edited by Siladitya Bhattacharya , Mark Hamilton Index More Information Index COCP. See combined oral disclosure of, 128–9 female, 13 contraceptive pill ethical dilemmas involving, 144–6 male, 45–6, 51–2 cohort total fertility rate (CTFR), 1 future relationship with, 127–8 thyroid, 8, 9 combined oral contraceptive pill implication discussion and endocrine tests, for males, 49, 51 (COCP), 20, 28, 29, 71 counselling for, 130, 131 endometrial polyps, 33, 36, 37, 40 co-morbidities, double jeopardy risks selection of, 127–8 endometrial receptivity array (ERA), for patients with, 140–1 dopamine agonists, 19 87 conception, prediction models for, double jeopardy risks, for patients with endometrial scratching, 84, 85, 86 54–6, 57, 63 co-morbidities, 140–1 endometrioma, 24, 26, 29, 36 confidentiality, 141 dye hydrotubation, 10 endometriosis, 22, 24 congenital anomalies, in children dysmenorrhoea, 24–5, 27 aetiopathogenesis of, 22–4 conceived by IVF/ICSI, 79 dyspareunia, 27 description, distribution and consequentialism, 138 classification of, 24, 25, 26 controlled ovarian stimulation. See EBM. See evidence-based medicine diagnosis of, 26–7, 28 ovarian stimulation ectopic pregnancy, 78 direct transplantation theory of, 23 corticosteroids, 90–1 ED. See erectile dysfunction economic burden of, 27–8 counselling EFI. See endometriosis fertility index epidemiology and risk factors of, before cross border reproductive egg. See oocyte 24–6 treatment, 132, 133 egg activation, artificial, 89, 103 genetic factors in, 23, 26 for donors, surrogates and partners, ejaculation, 43, 46–7, 49 immunological processes in, 23–4 130, 131 ejaculatory ducts, transurethral management of infertility associated for fertility preservation, 121 resection of, 52 with, 28–9 HFEA requirement for, 123, 124–5 elective egg freezing, 143–4 management of pain associated with, implication discussion in, 126, 130, elective single-embryo transfer (eSET), 29 131 108 organisation of care for, 29–30 offer of, 125 embryo, moral status of, 140 ovarian endometrioma, 24, 26, 29, in preparation for treatment, 124 embryo biopsy, 110–11 36 types of, 124–5 embryo cryopreservation prevalence of, 22 critical appraisal, literature, 150–4 ethical dilemmas in, 141–4 socioeconomic burden and cross border reproductive services for fertility preservation, 117–20 psychosocial impact of, 27–8 (CBRS), 131–2, 133 for IVF, 75–6 symptoms and signs of, 26–7, 28 cryopreservation. See also embryo laboratory procedure for, 108–9 uterine abnormalities, 33, 40 cryopreservation; oocyte embryo culture endometriosis fertility index (EFI), 24 cryopreservation buffer use in, 95–6 endometrium, luteal phase support of, ethical dilemmas in, 141–4 gas phase of, 103–5 75 gonadal tissue, 115, 117–20 in incubators, 96, 103, 104 environment, laboratory, 93–4 laboratory procedure for, 108–9 laboratory procedure for, 103–5 epidemiology of infertility, 1, 2–3, 4 ovarian tissue, 117–20 media for, 88, 105 epididymis, 48 sperm, 117, 141–4 pH of, 103 equipment, validation and verification testicular tissue, 117 embryo glue, 88 of, 162 cryostorage, 93, 120 embryo screening, 146 ERA. See endometrial receptivity array cryptorchidism, 45 embryo selection erectile dysfunction (ED), 47 CTFR. See cohort total fertility rate conventional assessment for, 105–6, eSET. See elective single embryo culture. See embryo culture 107 transfer cystectomy, 29 laboratory procedure for, 105–6, 107 ESGE. See European Society of cystic fibrosis (CF), 46, 48, 50 time lapse imaging for, 106 Gynaecological Endoscopy embryo transfer ESHRE. See European Society of Danazol, 28 catheters for, 73 Human Reproduction and data protection, 165 cleavage stage or blastocyst transfer, Embryology density centrifugation, buoyant, 97–8 74 ethical dilemmas, 136, 137, 146 diabetes, 47–8 double, 108 baby design, 146 diagnostic laparoscopy. See in IVF, 59, 62–3, 73–4 comparison of adoptive parent laparoscopy laboratory procedure for, 105, 106–8 selection to fertility treatment diagnostic test accuracy studies, 150 number of embryos transferred in, access, 138–9 diet, 25–6 74, 106–8 confidentiality, 141 DNA tests, sperm, 90 technique of, 73–4 consequentialism approach to, 138 document control system, 160–1 ultrasound use in, 73 double jeopardy risks for patients donors. See also third-party endocrine disorders. See also with co-morbidities, 140–1 reproduction hypothalamic pituitary disorders; fairness approach to, 139–40 assessment of, 129–30 ovulation disorders in fertility preservation, 120–1 168 © in this web service Cambridge University Press www.cambridge.org Cambridge University Press 978-1-108-81783-7 — Reproductive Medicine for the MRCOG Edited by Siladitya Bhattacharya , Mark Hamilton Index More Information Index in gamete cryopreservation, 141–4 patient assessment prior to, 116–17 for pituitary control in IVF, 70, 71 in gamete donation, 144–6 pregnancy outcomes in cancer gonadotropin-releasing hormone moral status of human embryos, 140 survivors, 120 analogues (GnRHa), 28, 29 in reproductive medicine versus preventative options for men, 121 gonadotropin-releasing hormone other branches of medicine, 136–7 preventative options for women, 121 (GnRH) antagonists rights-based system approaches storage options for men, 117 for fertility preservation, 118 to, 139 storage options for women, 117–20 OHSS prevention and, 77–8 welfare of potential people, 137–8, fertility rates, 1, 2–3 for pituitary control in IVF, 70–1 143, 145, 146 fertility sparing surgery, 121 gonadotropins ethical principles, 136, 137 fertility treatment access, 137–40 for endometrioma, 29 ethnicity, endometriosis risk and, 25 fibroids, uterine, 31–3,
Load more

Recommended publications
  • Te2, Part Iii
    TERMINOLOGIA EMBRYOLOGICA Second Edition International Embryological Terminology FIPAT The Federative International Programme for Anatomical Terminology A programme of the International Federation of Associations of Anatomists (IFAA) TE2, PART III Contents Caput V: Organogenesis Chapter 5: Organogenesis (continued) Systema respiratorium Respiratory system Systema urinarium Urinary system Systemata genitalia Genital systems Coeloma Coelom Glandulae endocrinae Endocrine glands Systema cardiovasculare Cardiovascular system Systema lymphoideum Lymphoid system Bibliographic Reference Citation: FIPAT. Terminologia Embryologica. 2nd ed. FIPAT.library.dal.ca. Federative International Programme for Anatomical Terminology, February 2017 Published pending approval by the General Assembly at the next Congress of IFAA (2019) Creative Commons License: The publication of Terminologia Embryologica is under a Creative Commons Attribution-NoDerivatives 4.0 International (CC BY-ND 4.0) license The individual terms in this terminology are within the public domain. Statements about terms being part of this international standard terminology should use the above bibliographic reference to cite this terminology. The unaltered PDF files of this terminology may be freely copied and distributed by users. IFAA member societies are authorized to publish translations of this terminology. Authors of other works that might be considered derivative should write to the Chair of FIPAT for permission to publish a derivative work. Caput V: ORGANOGENESIS Chapter 5: ORGANOGENESIS
    [Show full text]
  • Female Infertility: Ultrasound and Hysterosalpoingography
    s z Available online at http://www.journalcra.com INTERNATIONAL JOURNAL OF CURRENT RESEARCH International Journal of Current Research Vol. 11, Issue, 01, pp.745-754, January, 2019 DOI: https://doi.org/10.24941/ijcr.34061.01.2019 ISSN: 0975-833X RESEARCH ARTICLE FEMALE INFERTILITY: ULTRASOUND AND HYSTEROSALPOINGOGRAPHY 1*Dr. Muna Mahmood Daood, 2Dr. Khawla Natheer Hameed Al Tawel and 3 Dr. Noor Al _Huda Abd Jarjees 1Radiologist Specialist, Ibin Al Atheer hospital, Mosul, Iraq 2Lecturer Radiologist Specialist, Institue of radiology, Mosul, Iraq 3Radiologist Specialist, Ibin Al Atheer Hospital, Mosu, Iraq ARTICLE INFO ABSTRACT Article History: The causes of female infertility are multifactorial and necessitate comprehensive evaluation including Received 09th October, 2018 physical examination, hormonal testing, and imaging. Given the associated psychological and Received in revised form th financial stress that imaging can cause, infertility patients benefit from a structured and streamlined 26 November, 2018 evaluation. The goal of such a work up is to evaluate the uterus, endometrium, and fallopian tubes for Accepted 04th December, 2018 anomalies or abnormalities potentially preventing normal conception. Published online 31st January, 2019 Key Words: WHO: World Health Organization, HSG, Hysterosalpingography, US: Ultrasound PID: pelvic Inflammatory Disease, IV: Intravenous. OHSS: Ovarian Hyper Stimulation Syndrome. Copyright © 2019, Muna Mahmood Daood et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Citation: Dr. Muna Mahmood Daood, Dr. Khawla Natheer Hameed Al Tawel and Dr. Noor Al _Huda Abd Jarjees. 2019. “Female infertility: ultrasound and hysterosalpoingography”, International Journal of Current Research, 11, (01), 745-754.
    [Show full text]
  • Management of Reproductive Tract Anomalies
    The Journal of Obstetrics and Gynecology of India (May–June 2017) 67(3):162–167 DOI 10.1007/s13224-017-1001-8 INVITED MINI REVIEW Management of Reproductive Tract Anomalies 1 1 Garima Kachhawa • Alka Kriplani Received: 29 March 2017 / Accepted: 21 April 2017 / Published online: 2 May 2017 Ó Federation of Obstetric & Gynecological Societies of India 2017 About the Author Dr. Garima Kachhawa is a consultant Obstetrician and Gynaecologist in Delhi since over 15 years; at present, she is working as faculty at the premiere institute of India, prestigious All India Institute of Medical Sciences, New Delhi. She has several publications in various national and international journals to her credit. She has been awarded various national awards, including Dr. Siuli Rudra Sinha Prize by FOGSI and AV Gandhi award for best research in endocrinology. Her field of interest is endoscopy and reproductive and adolescent endocrinology. She has served as the Joint Secretary of FOGSI in 2016–2017. Abstract Reproductive tract malformations are rare in problems depend on the anatomic distortions, which may general population but are commonly encountered in range from congenital absence of the vagina to complex women with infertility and recurrent pregnancy loss. defects in the lateral and vertical fusion of the Mu¨llerian Obstructive anomalies present around menarche causing duct system. Identification of symptoms and timely diag- extreme pain and adversely affecting the life of the young nosis are an important key to the management of these women. The clinical signs, symptoms and reproductive defects. Although MRI being gold standard in delineating uterine anatomy, recent advances in imaging technology, specifically 3-dimensional ultrasound, achieve accurate Dr.
    [Show full text]
  • Anatomy of the Female Genital Tract and Its
    ANATOMY OF THE FEMALE GENITAL TRACT AND ITS ABNORMALITIES Olufemi Aworinde Lecturer/ Consultant Obstetrician and Gynaecologist, Bowen University, Iwo INTRODUCTION • The female genital tract is made up of the external and internal genitalia separated by the pelvic diaphragm. • The external genitalia is commonly referred to as the vulva and includes the mons pubis, labia majora, labia minora, clitoris, the vestibule and the vestibular glands. • The internal genitalia consists of the vagina, uterus, two fallopian tubes and a pair of ovaries. EXTERNAL GENITALIA MONS PUBIS • It’s a fibro-fatty pad covered by hair-bearing skin which covers the body of the pubic bones. LABIA MAJORA • Represents the most prominent feature of the vulva. They are 2 longitudinal skin folds, which contain loose adipose connective tissue and lie on either side of the vaginal opening. • They contain sebaceous and sweat glands and a few specialized apocrine glands. • Engorge with blood if excited EXTERNAL GENITALIA LABIA MINORA • Two thin folds of skin that lie between the labia majora, contain adipose tissue, but no hair. • Posteriorly, the 2 labia minora become less distinct and join to form the fourchette. • Anteriorly, each labium minus divides into medial and lateral parts. The lateral parts join to form the prepuce while the medial join to form the frenulum of the glans of the clitoris. • Darken if sexually aroused EXTERNAL GENITALIA CLITORIS • An erectile structure measuring 0.5-3.5cm in length, it projects in the midline and in front of the urethra. It consists of the glans, body and the crura. • Paired columns of erectile tissues and vascular tissues called the corpora cavernosa.
    [Show full text]
  • Study of Morphology of Uterus Using Ultrasound Scan P
    International Journal of Anatomy and Research, Int J Anat Res 2015, Vol 3(1):935-40. ISSN 2321- 4287 Original Article DOI: http://dx.doi.org/10.16965/ijar.2015.121 STUDY OF MORPHOLOGY OF UTERUS USING ULTRASOUND SCAN P. Priya 1, S. Vijayalakshmi *2. 1 Associate Professor, Dept. of Anatomy, Saveetha Medical College, Chennai, Tamil Nadu, India. *2 Associate Professor, Dept. of Anatomy, Saveetha Medical College, Chennai, Tamil Nadu, India. ABSTRACT Background: The anatomical variations of uterus particularly those concerning the body of uterus are well known in medical literature. Knowledge of these variations is important in reproductive periods of life, as well as in deciding the surgical procedures involving caesarean section delivery. However there are some exceptional variations in the body of uterus that may puzzle the obstetrician and gynaecologist dealing with gynaecological patients. Normal development of the female reproductive tract requires a complex series of events. Failure of any part of this process can result in congenital anomaly. Careful sonography and an awareness of the sonographic findings of early pregnancy in anomalous uteri should improve the detection of these anomalies. Recognition of such anomalies will also allow differentiation of those patients requiring repeat dilatation and curettage from those requiring laparotomy, as in the presence of a blind uterine horn or ectopic gestation. 3D ultrasonography permits the obtaining of planar reformatted sections through the uterus, which allow precise evaluation of fundal indentation & length of the septum. Aim This study was undertaken to assess the morphology of uterus and evaluate the anomalies. Materials: 1500 subjects within the age of 15-45 were assessed using ultrasound scan and the anomalies were analyzed.
    [Show full text]
  • Congenital Malformation of Female Genital Organs
    CONGENITAL MALFORMATION OF FEMALE GENITAL ORGANS DR. SHEEBA.S, ASSISTANT PROFESSOR, (DEPT OF OBG), SKHMC. INTRODUCTION From the embryological considerations, the following facts can be deduced. ♦ Developmental anomalies of the external genitalia along with ambiguity of sex are usually genetic in origin ♦ Major anatomic defect of the genital tract is usually associated with urinary tract abnormality (40%), skeletal malformation (12%), and normal gonadal function ♦ While minor abnormality escapes attention, it is the moderate or severe form, which will produce gynecologic and obstetric problem. DEVELOPMENT DEVELOPMENTAL ANOMALIES OF THE EXTERNAL GENITALIA UTERINE ANOMALIES UTERINE ANOMALIES • Class I: Müllerian agenesis/Hypoplasia segmental • Class II: Unicornuate uterus • Class III: Didelphys uterus • Class IV: Bicornuate uterus, • Class V: Septate uterus • Class VI: Arcuate uterus, • Class VII:Diethylstilbestrol (DES)-related abnormality. UTERINE ANOMALIES CLINICAL FEATURES OF UTERINE ANOMALIES Gynecological • Infertility and dyspareunia. • Dysmenorrhea in bicornuate uterus or due to cryptomenorrhea • Menstrual disorders (menorrhagia, cryptomenorrhea) Obstetrical • Midtrimester abortion • Rudimentary horn pregnancy • Cervical incompetence Clinical features RADIOLOGY HYSTEROSCOPIC VIEW OF A SEPTATE UTERUS PERINEAL OR VESTIBULAR ANUS ECTOPIC URETER DEVELOPMENTAL ANOMALIES OF THE EXTERNAL GENITALIA PERINEAL OR The entity is detected at birth VESTIBULAR The anal opening is situated either close to the ANUS posterior end of the vestibule or
    [Show full text]
  • Georgia Department of Public Health Birth Defects Registry Reporting Manual
    Georgia Department of Public Health Birth Defects Registry Reporting Manual 2019 Revision We Protect Lives Georgia Department of Public Health Birth Defects Program Staff Dr. J. Michael Bryan Director of Maternal and Child Health Epidemiology Jerusha E. Barton, MPH Birth Defects Epidemiologist, Newborn Surveillance Team Lead A. Elise Barnes, MPH Birth Defects Screening Epidemiologist 2 Georgia Department of Public Health Birth Defects Registry The Georgia Birth Defects Registry is housed within the Georgia Department of Public Health. The Georgia Birth Defects Registry staff prepared this reporting manual to provide guidance for submitting birth defects case reports. The manual contains directions for reporting birth defects, the case definition and information about reportable birth defects, and methods of reporting. The manual will be sent to each reporting contact to assist with complete and accurate reporting. We are interested in your feedback about the manual and suggestions about information you would like to receive. Birth Defects Registry staff can be reached at: Georgia Department of Public Health Birth Defects Registry 2 Peachtree Street NW Suite 14-133 Atlanta, GA 30303 Telephone number: (404) 463-0782 or (404) 463-5966 Fax number: (404) 463-1416 Email: [email protected] 3 Table of Contents General Information ............................................................................................................................................................... 6 Legislation and Confidentiality ...............................................................................................................................................
    [Show full text]
  • Application of Ultrasonography in Female Infertility: a Comprehensive Review Tochukwu C
    International Journal of Reproduction, Contraception, Obstetrics and Gynecology Okek e TC et al. Int J Reprod Contracept Obstet Gynecol. 2015 Oct;4(5):1246-1256 www.ijrcog.org pISSN 2320-1770 | eISSN 2320-1789 DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20150693 Review Article Application of ultrasonography in female infertility: a comprehensive review Tochukwu C. Okeke1*, Kennedy K. Agwuna2, Cyril C. Ezenyeaku3, Lawrence C. Ikeako3 1Department of Obstetrics & Gynecology, University of Nigeria Teaching Hospital, Enugu, Nigeria 2Department of Radiology, University of Nigeria Teaching Hospital, Enugu, Nigeria 3 Department of Obstetrics & Gynecology, Anambra State University Teaching Hospital, Amaku, Awka, Nigeria Received: 24 August 2015 Accepted: 09 September 2015 *Correspondence: Dr. Tochukwu C. Okeke, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT The quest for detailed evaluation of the uterus, fallopian tubes, and ovaries that is radiation free, inexpensive, readily available, non-invasive, relatively less time consuming and easily repeatable in female infertility has resulted in further studies. However, ultrasonography (US) remains the first line indispensable tool for gynecologic workup, monitoring and treating infertility. The aim is to review the current knowledge regarding the application of ultrasonography in female infertility. This was a descriptive review of ultrasonography in female infertility. We searched several databases (Medline, Google scholar, PubMed) with keywords “ultrasonography and female infertility”, “evaluation of female infertility”, “role of ultrasonography in female infertility:, and imaging in female infertility”.
    [Show full text]
  • Journal Lester W
    EDITOR VOLUME 170 NUMBER 1 • JANUARY | FEBRUARY 2018 ESTABLISHED 1844 D. LUKE GLANCY, MD ASSOCIATE EDITOR L.W. JOHNSON, MD BOARD OF TRUSTEES CHAIR, GEOFFREY W. GARRETT, MD VICE CHAIR, K. BARTON FARRIS, MD SECRETARY/TREASURER, RICHARD PADDOCK, MD ANTHONY P. BLALOCK, MD D. LUKE GLANCY, MD JOURNAL LESTER W. JOHNSON, MD OF THE LOUISIANA STATE MEDICAL SOCIETY FRED A. LOPEZ, MD EDITORIAL BOARD MURTUZA J. ALI, MD RONALD AMEDEE, MD SAMUEL ANDREWS, II, MD BOB BATSON, MD EDWIN BECKMAN, MD FEATURED ARTICLES GERALD S. BERENSON, MD C. LYNN BESCH, MD JOHN BOLTON, MD 2 ASSESSING PSYCHOLOGICAL RESILIENCE AMONG PRE-SURGERY PLIF PATIENTS BRIAN BOULMAY, MD MICHELLE BOURQUE, JD IN LOUISIANA: PSYCHOMETRIC EVALUATION OF THE BRIEF RESILIENT COPING JAMES N. BRAWNER, III, MD SCALE BRETT CASCIO, MD Scott Wilks, PhD, Stephen Guillory, PA-C, Jennifer Geiger, MSW, Kevin Goodson, MD, QUYEN CHU, MD WILLIAM PATRICK COLEMAN III, MD Tatiana Begault, BS, Zibei Chen, MSW, Jorge Isaza, MD RICHARD COULON, MD LOUIS CUCINOTTA, MD VINCENT A. CULOTTA, JR., MD 6 COMBINED SURGICAL ONCOLOGY AND NEUROSURGERY APPROACH FOR JOSEPH DALOVISIO, MD RESECTION OF SACRAL CHORDOMA NINA DHURANDHAR, MD Racheal Wolfson, MD, Richard Menger, MD, MPA, Ouyen Dinh Chu, MD, MBA, JAMES DIAZ, MD, MPH & TM, DR. PH JOHN ENGLAND, MD Anthony Sin, MD JULIO FIGUEROA, MD ELIZABETH FONTHAM, MPH, DR. PH 10 INTRACRANIAL SEPTUM PELLUCIDUM DYSEMBRYOPLASTIC NEUROEPITHELIAL EDWARD FOULKS, MD BEN GUIDER, MD TUMOR: CASE PRESENTATION AND REVIEW OF PEDIATRIC SEPTUM PELLUCIDUM HENRY G. HANLEY, MD TUMORS ELIAS B. HANNA, MD LYNN H. HARRISON, JR., MD Rimal Dossani, MD, Devi Patra, MD, Nimer Adeeb, MD, Elizabeth Wild, MD, ROBERT HEWITT, MD Abhilasha Ghildyal, MD, Marjorie Fowler, MD, Christina Notarianni, MD MICHAEL HILL, MD LARRY HOLLIER, MD JOHN HUNT, MD 15 NEWBORN SCREENING FOR CONGENITAL ADRENAL HYPERPLASIA: REVIEW OF BERNARD JAFFE, MD UNDETECTED CASES IN LOUISIANA NEERAJ JAIN, MD TRENTON L.
    [Show full text]
  • The Role of Laparoscopy in Paediatric and Adolescent Gynaecology
    Review paper Pediatric surgery Videosurgery The role of laparoscopy in paediatric and adolescent gynaecology Aleksandra Raźnikiewicz, Wojciech Korlacki, Andrzej Grabowski Department of Children’s Developmental Defects Surgery and Traumatology, Medical University of Silesia, Katowice, Poland Videosurgery Miniinv 2020; 15 (3): 424–436 DOI: https://doi.org/10.5114/wiitm.2020.97817 Abstract Paediatric and adolescent gynaecology is a narrow field of medicine dealing with the diagnosis of and treatment of gynaecological diseases from the neonatal period to sexual maturity. The current trend in surgical gynaecology in the paediatric population is to minimise the degree of invasiveness of diagnostic and therapeutic procedures. This contributes to reducing the number of complications and the risk of infertility. Laparoscopic procedures are a chal- lenge for paediatric surgeons and gynaecologists, not only because of the age of treated patients, and anatomical and physiological differences between different age groups but also because of the complexity of the pathology, the differentiation of cancer tumours, and the presence of congenital developmental defects. Key words: laparoscopy, congenital defects, ovarian torsion, ovarian cyst, paediatric gynaecology. Introduction der edge, relatively smaller uterine fundus, extended cervix, longer fallopian tube, small volume, and high- Laparoscopic surgery has many well-document- er ovary position. Special attention should be paid ed advantages, such as better visualisation of the to the prevention of fertility preservation in patients surgical field, less postoperative pain, shorter hos- operated on due to adnexa pathology or congeni- pitalisation time and convalescence, lower risk of tal defects [2]. The risk of postoperative adhesion postoperative adhesions, and better cosmetic re- formation in minimally invasive laparoscopic proce- sults.
    [Show full text]
  • JKAUSCIMED-V22-2-FINAL MRV-ORIGINAL 21X28.Indd
    The Role of Laparoscopy in Management of Congenital Anomalies of the Müllerian System: Literature Review and Case Series E.A. Aljahdali REVIEW ARTICLE The Role of Laparoscopy in Management of Congenital Anomalies of the Müllerian System: Literature Review and Case Series Ettedal A. Aljahdali, MBBCH, SBOG, CBG OBGYN AFSA Department of Obstetrics and Gynecology, Faculty of Medicine King Abdulaziz University, Jeddah, Saudi Arabia Correspondence Abstract Dr. Ettedal A. Aljahdali Structural defects of the female reproductive tract become apparent P.O. Box 80215, Jeddah 21589, Saudi Arabia e.M: [email protected] at varying chronologic times during intrauterine life. The diagnosis of all female reproductive tract abnormalities has benefi ted from Submission: 17 Dec. 2014 enhancements in imaging techniques and the surgical treatment Accepted: 9 Feb. 2015 thereof has improved due to advances in the techniques and instrumentation of both surgical and non-surgical procedures. In the Citation Aljahdali EA. The role of laparoscopy in last decade, laparoscopy has become increasingly popular and has management of congenital anomalies of the successfully replaced several open surgical procedures. It has been Müllerian system: Literature review and case applied to many aspects of gynecological surgery and has become series. JKAU Med Sci 2015; 22 (2): 39-46. DOI: the procedure of choice for gynecological surgery. A review of the 10.4197/Med. 22.2.6 recent literature continues to support the utilization of laparoscopy for the management of genital tract malformation. This review aims to appraise the recent literature to determine how laparoscopy may aid in the diagnosis of reproductive tract anomalies and their treatment, its success in replacing the open surgery in some cases, and the presentation of some cases that were successfully diagnosed and treated with laparoscopy.
    [Show full text]
  • DEVELOPMENTAL ABNORMALITIES of MULLERIAN DUCT- a REVIEW Kowsalya.R.G1, Padmasaritha.K2, Ramesh M3
    INTERNATIONAL AYURVEDIC MEDICAL JOURNAL International Ayurvedic Medical Journal, (ISSN: 2320 5091) (March, 2017) 5 (3) DEVELOPMENTAL ABNORMALITIES OF MULLERIAN DUCT- A REVIEW Kowsalya.R.G1, Padmasaritha.K2, Ramesh M3 1PG Scholar, 2Assistant professor, 3Professor; Dept of PTSR, Sri Kalabyreshwara Swamy Ayurvedic College and Hospital And Research Centre, Vijayanagar, Bangalore, Karnataka, India Email: [email protected] ABSTRACT The beeja (sukra and artava rupa) has chromosomes with genes representing the future organs to be developed. Any abnormality in the beeja, beejabhaga, beejabhagaavayava leads to various conge- nital abnormalities in foetus. Mullerian duct anomalies are one of the congenital abnormalities of the female reproductive tract resulting from failure in the development of the Mullerian ducts and their as- sociated structures. Their cause has yet to be fully clarified, and it is currently believed to be multi fac- torial. Symptoms appear during adolescence or early adulthood, and affect the reproductive capacity of these women. When clinically suspected, investigations leading to diagnosis include imaging methods such as hysterosalpingography, ultrasonography and MRI. Mullerian duct anomalies consist of a wide range of defects that may vary from patient to patient. The aim is to understand the congential malfor- mation of mullerian duct through Ayurveda. Keywords: Beeja, Beejabhaga, Mullerian duct anomalies. INTRODUCTION The beeja and its component are the subtle form bhagas lead to defective formation of the garb- of the future organs and parts of the body and hasaya and artava in fetus. Different degrees of the particular parts consequently develop into mullerian duct anomalies can be considered as the specific organs and parts. Acharyas states defective formation of garbhasaya and artava.
    [Show full text]